Harbor醫療保健主動型ETF MEDI 深 滬
已收盤 11-06 16:00:00 美东时间
35.12
+0.280
+0.80%
華盛通- 最 高35.17
- 今 開34.57
- 成交量 1.80万股
- 最 低 34.44
- 昨 收 34.84
- 總市值 4565.60万
- 52周最高 36.36
- 市盈率 靜 --
- 換手率 1.38%
- 52周最低 27.50
- 委 比 0.00%
- 總股本 130.00万
- 歷史最高 36.36
- 量 比 0.64
- 振 幅 2.10%
- 歷史最低 18.9464
- 每 手 1
- 風險率 1.65%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多Can One Man Save the World? Possibly!
Gaia has acquired exclusive streaming rights to Gabe Polsky's documentary *The Man Who Saves the World?*, executive produced by Peter Farrelly and Danny McBride. The film follows Patrick McCollum, a spiritual leader who believes he is destined to fulfill an ancient Indigenous prophecy by uniting tribes, protecting the Amazon, and potentially saving humanity. The documentary, available in multiple languages, premieres on Gaia on November 6, 2026, ...
11-06 05:00
Uniti Group Inc. to Participate at the J.P. Morgan 2026 U.S. Opportunities Forum
Uniti Group Inc. announced that its Chief Financial Officer and Treasurer, Paul Bullington, will participate in a panel at the J.P. Morgan 2026 U.S. Opportunities Forum in Miami on November 12, 2026. Uniti is a leading fiber provider offering mission-critical connectivity across the U.S., serving over a million consumers and businesses through its portfolio of brands, including Uniti Wholesale, Kinetic, Uniti Fiber, and Uniti Solutions.
11-05 21:15
McEwen Exercises Inventus Warrants and Increases Ownership to 12.7%
McEwen Inc. announced that it acquired 9.2 million common shares of Inventus Mining Corporation by exercising warrants at CAD$0.12 per share, totaling CAD$1.104 million. This purchase increased McEwen's ownership from 20 million shares (9%) to 29.2 million shares (12.7%). The acquisition was made for investment purposes, and McEwen reserves the right to buy or sell additional securities of Inventus based on market conditions. McEwen is a mining c...
11-05 16:44
Magna Announces Renewal of Normal Course Issuer Bid
Magna International Inc. has been approved by the Toronto Stock Exchange to renew its normal course issuer bid (NCIB), allowing it to repurchase up to 25,778,000 Magna Common Shares, approximately 10% of its public float. The NCIB will be effective from November 9, 2026, to November 8, 2027. The repurchases will be used for cancellation or to fund stock-based compensation programs. Shares may be bought on the TSX, NYSE, or through alternative tra...
11-05 11:30
Powering the Play: Verizon Elevates the NFL Gameday Experience Worldwide
Verizon is enhancing the 2026 NFL season with advanced technology, including connected officiating devices, global network expansion, and stadium upgrades. Officials use Verizon-powered watches for real-time data, while the network expands to nine international games. Stadium investments feature 5G upgrades to meet high fan data demands, ensuring seamless connectivity for fans, coaches, and officials.
11-04 14:00
Medicus Pharma Announces Proposed SkinJect® Business Combination and Concurrent Financing
Medicus Pharma Ltd. subsidiary SkinJect, Inc. has entered into a non-binding letter of intent with a SPAC for a proposed $135 million business combination to establish a dedicated platform for its rare-disease dermatology program in Gorlin syndrome. The transaction would allow Medicus to retain majority ownership while securing financing for the SKNJCT-005 NDA-enabling study. SkinJect’s investigational microneedle patch delivers doxorubicin for b...
11-04 13:30
Phathom Pharmaceuticals to Participate in November Investor Conferences
Phathom Pharmaceuticals announced that its management team will participate in three upcoming investor conferences: the Guggenheim 3rd Annual Healthcare Innovation Conference in Boston on November 10, 2026; the Stifel 2026 Healthcare Conference in New York on November 11, 2026; and the Jefferies Global Healthcare Conference in London on November 18, 2026. The company’s leadership will engage in fireside chats and one-on-one meetings at each event...
11-04 13:00
uniQure Announces Third Quarter 2026 Financial Results and Provides Company Update
FDA has granted priority review for uniQure's BLA for AMT-130 (ifezuntirgene inilparvovec) in Huntington's disease, with a PDUFA target action date of May 1, 2027. The company has aligned with FDA on the confirmatory study design and expects to begin patient screening in the U.S. by end of 2026. uniQure reported $768.4 million in cash, cash equivalents, and investment securities as of September 30, 2026, expected to fund operations into 2030. Thi...
11-04 12:05
Transocean Ltd. Provides Quarterly Fleet Status Report
Transocean Ltd. issued a quarterly Fleet Status Report, highlighting updates on its offshore drilling rigs. The Deepwater Conqueror secured contracts for two wells in Equatorial Guinea and five wells in the U.S. Gulf. The Deepwater Proteus received a five-well contract in the U.S. Gulf and an optional 60-day well. Dhirubhai Deepwater KG2 secured a two-year contract with ONGC in India, while Transocean Norge and Transocean Equinox also secured new...
11-02 21:23
Bath & Body Works Gives A Thousand Wishes New Ways to Shine
Bath & Body Works is expanding its iconic "A Thousand Wishes" fragrance collection with two new scents: "A Thousand Wishes Granted" and "A Thousand Crystal Wishes." The collection introduces solid perfume formats for both fragrances, offering a convenient and portable way to enjoy the scents. "A Thousand Crystal Wishes" is a limited-edition eau de parfum featuring Swarovski crystals, available in only 1,000 individually numbered bottles. Global f...
11-02 21:03
